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Abstract
The rise in type 1 diabetes (T1D) incidence in recent decades is probably related to modifications in environmental factors.
Viruses are among the putative environmental triggers of T1D. The mechanisms regulating beta cell responses to viruses,
however, remain to be defined. We have presently clarified the signaling pathways leading to beta cell apoptosis following
exposure to the viral mimetic double-stranded RNA (dsRNA) and a diabetogenic enterovirus (Coxsackievirus B5). Internal
dsRNA induces cell death via the intrinsic mitochondrial pathway. In this process, activation of the dsRNA-dependent
protein kinase (PKR) promotes eIF2a phosphorylation and protein synthesis inhibition, leading to downregulation of the
antiapoptotic Bcl-2 protein myeloid cell leukemia sequence 1 (Mcl-1). Mcl-1 decrease results in the release of the BH3-only
protein Bim, which activates the mitochondrial pathway of apoptosis. Indeed, Bim knockdown prevented both dsRNA- and
Coxsackievirus B5-induced beta cell death, and counteracted the proapoptotic effects of Mcl-1 silencing. These observations
indicate that the balance between Mcl-1 and Bim is a key factor regulating beta cell survival during diabetogenic viral
infections.
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Introduction
Type 1 diabetes (T1D) is a chronic autoimmune disease
characterized by the progressive and selective destruction of the
insulin-producing pancreatic beta cells [1]. It mainly affects
individuals during childhood or adolescence and requires a life-
long treatment with insulin, which at the US represents a cost of
$14.4 billion per year [2]. Triggering of diabetes results from an
interaction between genetical and environmental factors. Most
candidate genes for T1D are supposed to act at the immune
system level [3], but we have recently shown that nearly 30% of
these candidate genes are also expressed in beta cells and may
modulate their responses after exposure to potential environmen-
tal factors [4]. These findings indicate that beta cells are not only
targets, but also actors of T1D pathophysiology [4].
The incidence of T1D is increasing 3.9% per year in Europe,
especially among the youngest population (,5 years-old) in which
a doubling in the number of new cases is expected between 2005
and 2020 [5]. An explanation for this rapid augment in T1D
incidence may be the increased exposure to diabetogenic
environmental factors. Viruses are among the potential environ-
mental causes of T1D [6], as suggested by epidemiological [7],
experimental [8] and clinical data [9].
Enterovisuses (EV) such as Coxsackievirus B (CVB) [10], are the
main candidates. Coxsackievirus B4 was isolated from a child who
died of diabetic ketoacidosis and this virus induced diabetes in
mice [11]. Among the Coxsackievirus, CVB5 is the most dele-
terious prototype strain for human pancreatic islets [12]. An
increase of T1D incidence has been described after epidemics of
CVB5 [13] and these epidemics are frequent in Finland, the
country with the highest incidence of T1D [14].
The pathogenic role of viruses in T1D might involve damage to
beta cells and the local induction of proinflammatory mediators
[1]. CVB-infected pancreatic beta cells can be phagocyted by both
macrophages [15] and dendritic cells [16], leading to activation of
the immune system, presentation of islet autoantigens and release
of cytokines/chemokines. Local injury of beta cells induced by
dsRNA, a by-product of viral replication, promotes autoimmune
diabetes in animal models [17]. Both the viral mimetic dsRNA
[18] and Coxsackievirus [19] induce beta cell apoptosis, but the
mechanisms involved remain to be clarified.
Apoptotic cell death can be initiated by two signaling cascades,
namely the intrinsic and the extrinsic pathways. The intrinsic
pathway is the main pathway for endoplasmic reticulum (ER)
stress and cytokine-induced beta cell apoptosis [20,21,22,23]. In
this pathway, a disequilibrium between the antiapoptotic and the
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proapoptotic Bcl-2 family members [24] leads to activation of Bcl-
2-associated X protein (BAX) and Bcl-2 antagonist or killer (BAK)
and the consequent permeabilization of mitochondrial outer
membrane. This allows cytochrome c release to the cytoplasm
and the assembly of the apoptosome. The apoptosome then
recruits and activates the initiator caspase 9, which cleaves and
activates the effector caspase 3, leading to execution of apoptosis
[25].
We have presently investigated the molecular pathways
involved in dsRNA and viral-induced beta cell apoptosis. Similar
to ER stress and cytokine-induced apoptosis [24], the viral by-
product dsRNA activates the intrinsic pathway of apoptosis. The
nature of the Bcl-2 family members involved is, however, different.
Thus, dsRNA-dependent protein kinase (PKR) activation by
cytoplasmic dsRNA leads to phosphorylation of the elongation
factor eIF2a. The eIF2a phosphorylation promotes inhibition of
protein translation, which is followed by an early and progressive
decrease in the expression of the antiapoptotic myeloid cell
leukemia sequence 1 (Mcl-1) protein. Decreased expression of
Mcl-1 allows the proapoptotic protein Bim to activate BAX,
leading to cytochrome c release, caspase 9 and 3 activation and
beta cell apoptosis. Similar findings were observed during viral
infection of pancreatic beta cells by CVB5. These observations
clarify the mechanisms involved in viral-induced apoptosis in
pancreatic beta cells, and suggest that usage of Bcl-2 proteins is
context-dependent during beta cell apoptosis initiated by different
stimuli.
Results
Internal dsRNA induces beta cell apoptosis via the
intrinsic mitochondrial pathway of apoptosis
Transfection with the synthetic dsRNA polyinosinic-polycy-
tidylic acid (PIC) induced beta cell apoptosis already after 12h,
with progressive increase up to 24h (Figure 1A). To characterize
the pathways involved in beta cell apoptosis, BAX translocation to
the mitochondria was analyzed by immunocytochemistry. Intra-
cellular dsRNA promoted the translocation of BAX (Figure 1B)
and the release of cytochrome c from the mitochondria to the
cytoplasm (Figures 1C and D). This activated the initiator caspase
9 and effector caspase 3 (Figure 1E), characterizing induction of
the intrinsic mitochondrial pathway of apoptosis.
Expression of antiapoptotic Bcl-2 family members
regulates beta cell apoptosis and is decreased upon
exposure to internal dsRNA
The antiapoptotic Bcl-2 protein Mcl-1 is an important regulator
of beta cell death after exposure to proinflammatory cytokines and
ER stressors [20]. Mcl-1 protein expression gradually decreased
from 6h until 24h after PIC transfection (Figure 2A). This
reduction in Mcl-1 protein was a post-transcriptional effect since
Mcl-1 mRNA expression was in fact increased at 24h (Figure 2B).
Mcl-1 is targeted for degradation at the proteasome [26]. INS-1E
cells treated with the proteasome inhibitor MG-132 (same
experimental conditions as in [20,22]) had increased basal Mcl-1
expression, and the inhibitor partially prevented dsRNA-induced
decrease in Mcl-1 expression (Figure 2C), suggesting that
proteasomal degradation contributes at least in part for the
observed Mcl-1 downregulation. Mcl-1 knockdown by two
previously validated siRNAs [20] exacerbated cleavage of caspases
9/3 (Figure 2D) and PIC-induced apoptosis in INS-1E cells
(Figure 2E) and FACS-purified primary beta cells (Figure 2F). On
the other hand, overexpressing rat Mcl-1 by the use of an
adenoviral vector (adMcl-1 [20]) prevented the activation of
caspases 9/3 and reduced by. 40% apoptosis induced by dsRNA
(Figures 2G, H and I). This is a specific effect, since infection with
a control adenovirus encoding luciferase (adLuc) did not modify
apoptosis (Figures 2H and I) and Mcl-1 silencing or overexpression
did not modify expression of Bcl-XL or Bcl-2 (data not shown).
These observations indicate a key role for Mcl-1 decrease in
dsRNA-induced apoptosis.
The two other key antiapoptotic Bcl-2 proteins in beta cells are
Bcl-XL and Bcl-2 [24]. Bcl-XL but not Bcl-2 protein expression was
decreased after PIC exposure (Supplemental Figures S1A and B).
This downregulation, however, was only detected at later time-
points (after 12h and 24h) and to a lesser extent than observed with
Mcl-1 (compare Figure 2A and Supplemental Figure S1A). Bcl-XL
and Bcl-2 knockdown (Supplemental Figures S1C and D) increased
basal beta cell apoptosis from 7% to more than 30% and further
increased PIC-induced apoptosis, as compared to siControl
(Supplemental Figures S1E and F). As observed with siMcl-1,
inhibition of Bcl-XL and Bcl-2 promoted caspases 9 and 3 cleavage
in parallel with beta cell apoptosis (Supplemental Figures S1G and
H). Similar results were observed with second independent siRNAs
against Bcl-XL and Bcl-2 (Supplemental Figure S2). Nevertheless,
when the effects of Bcl-XL or Bcl-2 silencing on PIC-induced
apoptosis were corrected by their basal levels of apoptosis using the
apoptotic index (i.e. siBcl-XL or Bcl-2 + PIC correct by siBcl-XL or
Bcl-2 alone [27]) they were not different from the control group
(siControl + PIC) (Supplemental Figure S3). This finding suggests
that knocking down these proteins has only additive effect to PIC-
induced apoptosis. On the other hand, Mcl-1 knockdown using two
different siRNAs resulted in increased apoptotic indexes as
compared to siControl, indicating that silencing of Mcl-1, different
from Bcl-XL and Bcl-2, potentiates apoptosis caused by PIC
(Supplemental Figure S3A).
The proapoptotic BH3-only protein Bim regulates
pancreatic beta cell apoptosis after dsRNA exposure
The BH3-only protein Bim was previously shown to be an
important regulator of glucose-mediated beta cell apoptosis [28]
and virus-induced cell death in other cell types [29]. Against this
Author Summary
The global prevalence of type 1 diabetes (T1D) is
approximately 20 million individuals, and projections
indicate that this will double in the coming decades. This
increase in T1D incidence is probably related to modifica-
tion in the exposure to environmental factors. Viruses are
one of the putative environmental agents that trigger T1D.
The mechanisms leading to beta cell loss during viral
infection, however, remain to be clarified. The present
study aimed to clarify the mechanisms of dsRNA- and
virus-induced beta cell demise. Thus, dsRNA produced
during viral replication in beta cells induces activation of
the kinase PKR. This kinase phosphorylates the elongation
factor eIF2a promoting inhibition of protein synthesis
which decreases the short-life antiapoptotic protein Mcl-1.
Decline of Mcl-1 allows Bim to exert its proapoptotic
effects by activation of the intrinsic pathway of apoptosis.
In conclusion, we demonstrate that the balance Mcl-1/Bim
is central for dsRNA- and enterovirus-induced beta cell
apoptosis. This clarifies one of the key questions in early
T1D pathogenesis, namely the mechanisms behind viral-
induced beta cell apoptosis, and the subsequent trigger-
ing of insulitis.
Mechanisms of Viral-Induced Beta Cell Apoptosis
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background, we evaluated its role in dsRNA-induced beta cell
apoptosis. Time-course experiments with INS-1E cells exposed to
intracellular PIC did not show modifications in the expression of
the Bim isoforms EL, L and S (Figure 3A). Since Bim may
modulate apoptosis independently of changes in its expression
[30], we next evaluated whether Bim knockdown affects dsRNA-
induced apoptosis. The use of a specific siRNA against Bim
inhibited by . 70% its protein expression at both basal and PIC-
induced conditions (Figure 3B). Bim knockdown prevented PIC-
induced apoptosis in INS-1E cells (Figure 3C) and in primary beta
Figure 1. Internal dsRNA induces beta cell death via the mitochondrial pathway of apoptosis. A. INS-1E cells were transfected with the
synthetic dsRNA polyinosinic-polycytidylic acid (PIC) and apoptosis was evaluated at different time points using nuclear dyes as described in Methods
(n = 5, *P,0.01 vs. untreated). B. BAX localization was studied by immunocytochemistry in INS-1E cells exposed or not to internal dsRNA for 24h.
Pictures are representative of 4 independent experiments; arrows indicate BAX mitochondrial localization, similar to the ATP Synthase (mitochondrial
marker) C. Cytochrome c release in INS-1E cells treated for 24h in the presence or absence of intracellular dsRNA. Pictures are representative of 4
independent experiments. D. Western blot quantified by densitometry of cytoplasmic protein fractions in INS-1E cells transfected or not with dsRNA
for 24h (n = 4, *P,0.01 vs. untreated). E. Western blot analysis and densitometry of cleaved caspases 9 and 3 after INS-1E cells exposure to internal
dsRNA at different time points (n = 5–6, *P,0.05, **P,0.01 vs. untreated). Data are mean 6 SEM.
doi:10.1371/journal.ppat.1002267.g001
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Figure 2. Mcl-1 protein expression is decreased by internal dsRNA and its modulation regulates beta cell apoptosis. A. INS-1E cells
were transfected with dsRNA for different time points and Mcl-1 expression was analyzed by Western blot (top) and quantified by densitometry
(bottom; data are shown as fold-change compared to non-treated cells; -) (n = 3, *P,0.01 vs. untreated). B. mRNA expression of Mcl-1 in INS-1E cells
treated or not with internal dsRNA for 24h (n = 5, *P,0.01 vs. untreated). Results are corrected for the housekeeping gene GAPDH. C. INS-1E cells
were treated or not for 12h with the proteasome inhibitor MG-132 in the presence or absence of intracellular PIC and Mcl-1 expression was analyzed
by Western blot (top) and quantified by densitometry (bottom; data are shown as fold-change compared to non-treated cells; -) (n = 4, *P,0.01 vs.
control (untreated),#P,0.05 vs. PIC alone). D, E and F. INS-1E cells (D and E) or FACS-purified primary beta cells (F) were transfected with siControl or
with two different small-interfering RNAs against Mcl-1 (siMcl-1 and siMcl-1 #2) for 48h, as described in Methods. D. Protein expression of Mcl-1 and
cleaved caspases 9 and 3 was evaluated by Western blot. Pictures are representative of 3 independent experiments. E and F. dsRNA-induced
Mechanisms of Viral-Induced Beta Cell Apoptosis
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cells (Figure 3H). These results were confirmed with a second
siRNA against Bim (Supplemental Figure S4). In agreement with
the effects on cell viability, PIC-induced activation of caspases 9
and 3 was also reduced after inhibition of Bim (Figure 3D). We
studied two other proapoptotic BH3-only proteins, namely Death
Protein-5 (DP5) and p53 Up-regulated Modulator of Apoptosis
(PUMA), previously shown to regulate cytokine-induced beta cell
apoptosis [21,31]. We obtained a knockdown of .80% for DP5
and .75% for PUMA mRNA expression (Supplemental Figures
S5A and C); however, differently from what was observed
following Bim silencing, neither siDP5 nor siPUMA prevented
PIC-triggered apoptosis (Supplemental Figures S5B and D).
One of the mechanisms by which the antiapoptotic Bcl-2
proteins act is via binding and inactivating specific proapoptotic
BH3-only proteins [32]. We thus performed co-immunoprecipi-
tation studies to evaluate the association between Bim and Mcl-1.
Bim was immunoprecipitated using a specific polyclonal antibody
and the presence of Mcl-1 in the precipitated material was
determined with an anti-Mcl-1 antibody. We observed that at
basal condition Bim was bound to Mcl-1, but after 24h of PIC
exposure there was a clear decrease in the association between
these two proteins, confirming that Bim is liberated from Mcl-1
following dsRNA exposure (Figure 3E).
To evaluate whether the PIC-induced decrease in Mcl-1 protein
expression contributes to beta cell apoptosis by hampering Bim
inactivation by Mcl-1, we performed double-knockdown (siMcl-1
+ siBim) and evaluated apoptosis and cleavage of caspases 9 and 3
in comparison to single knockdown (siMcl-1 or siBim). The
combined use of siMcl-1 plus siBim produced a.70% suppression
of the target genes, as observed with the use of these siRNAs
individually (data not shown). Interestingly, the double-silencing of
siMcl-1 + siBim prevented the proapoptotic effect caused by Mcl-1
knockdown in INS-1E cells (Figures 3F and G) and primary beta
cells (Figure 3H), suggesting that the release of Bim from the Mcl-
1/Bim complex induced by both dsRNA and siMcl-1 is a key
effector of beta cell apoptosis.
Infection of beta cells by Coxsackievirus B5 induces the
mitochondrial apoptosis pathway through the BH3-only
protein Bim
To assess whether the above described pathways are also
relevant in the context of a viral infection of beta cells, we infected
INS-1E cells and FACS-purified rat beta cells with Coxsackievirus
B5. First, we confirmed that this enterovirus infects rat beta cells at
the different MOIs tested by determining the presence of the viral
capsid (VP1 and 2) (Figures 4A, E and F). The viral capsid was
already detected in the cells at 8h post-infection and its expression
increased further up to 24h (data not shown; Figures 4A and F).
Infection of beta cells at these MOIs induced cell death mainly by
apoptosis (Figure 4B) via the intrinsic pathway (Figures 4C and F),
as observed with internal dsRNA (Figure 1). In line with these
observations, Bim silencing significantly decreased virus-induces
apoptosis (Figures 4D and G) and caspase 9 and 3 activation
(Figure 4E). Importantly, inhibition of virus-induced apoptosis by
knocking down Bim did not modify the amount of viral capsids
(VP1 and 2; Figure 4E), indicating that, under the present
experimental conditions, inhibition of apoptosis did not exacerbate
viral replication in beta cells. These observations suggest that both
dsRNA and the potentially diabetogenic virus CVB5 induce a
similar pathway of apoptosis in beta cells. Interestingly, both
dsRNA and CVB5 induced expression of interferon b (Supple-
mental Figure S6A and B) and interferon a (data not shown), but
with different kinetics. Expression of interferon b mRNA was
several-fold higher in primary beta cells as compared to INS-1E
cells (Supplemental Figure S6C). This increased expression of type
I interferons may also contribute to the observed in vitro beta cell
apoptosis, as suggested by previous studies [33].
dsRNA-induced decrease in Mcl-1 protein expression
depends on eIF2a phosphorylation by dsRNA-dependent
protein kinase (PKR)
Two important regulators of Mcl-1 protein expression have
been reported in pancreatic beta cells, namely phosphorylation of
eIF2a and c-Jun N-terminal Kinase (JNK) activation [20]. Taking
this into account we evaluated the time course phosphorylation of
eIF2a and JNK in INS-1E cells transfected with PIC. Both eIF2a
and JNK were activated by PIC, but with different profiles. Thus,
eIF2a phosphorylation started earlier (2h), had a peak at 6h then
slowly decreased up to 24h (Figure 5A); JNK phosphorylation
started later (6h), reached a plateau at 12h and remained
upregulated up to 24h (Figure 5B).
JNK inhibition by a specific chemical inhibitor [34], did not
prevent Mcl-1 protein decrease (Supplemental Figure S7). We also
evaluated the expression of the BH3-only protein Noxa previously
shown to induce proteosomal degradation of Mcl-1 [35], but did
not detect its expression in beta cells (data not shown).
PKR-like endoplasmic reticulum kinase (PERK) and PKR were
evaluated as two possible mediators of the eIF2a phosphorylation
induced by PIC [36,37]. PERK is a kinase activated by endoplasmic
reticulum (ER) stress [36], while PKR is a classic downstream
response to dsRNA/viruses [37]. Thapsigargin, a well-know ER
stressor [34], was used as positive control for PERK activation.
Differently from thapsigargin, PIC did not induce PERK
phosphorylation, while it clearly induced eIF2a phosphorylation
(Supplemental Figures S8A and B), indicating that another
upstream kinase is responsible for this effect. We thus evaluated
the role of PKR in this process by using a specific siRNA against
PKR which inhibited PKR protein expression by .80%
(Figure 6A). Knockdown of PKR almost completely prevented
PIC-induced eIF2a phosphorylation and the dsRNA-induced Mcl-
1 decrease (Figures 6B and C); there was even an increase in Mcl-1
expression under this condition. In line with the observed increase
in Mcl-1 protein expression, silencing of PKR reduced caspases 9
and 3 cleavage (Figure 6D) and PIC-induced apoptosis (Figure 6E).
Similar results were obtained with a second siRNA against PKR
(data not shown), confirming the key role for PKR in dsRNA-
induced Mcl-1 decrease and consequent beta cell apoptosis.
Discussion
We presently show that intracellular dsRNA activates the
intrinsic pathway of apoptosis in pancreatic beta cells. Triggering
apoptosis in INS-1E cells (E) and FACS-purified primary beta cells (F) treated for 24 h with PIC with or without Mcl-1 knockdown (n= 5, *P,0.01 vs.
siControl, #P,0.01 vs. siControl + PIC). G, H and I. INS-1E cells (G and H) or FACS-purified primary beta cells (I) were infected or not (NI) with
adenovirus encoding the luciferase gene (adLuc) or rat Mcl-1 (adMcl-1) at different multiplicities of infection (MOI) for 48h, as indicated. G. Protein
expression of Mcl-1 or cleaved caspases 9 and 3 were evaluated by Western blot 24h after PIC exposure. Pictures are representative of 3 independent
experiments. H and I. dsRNA-induced apoptosis in INS-1E cells (H) and FACS-purified primary beta cells (I) treated for 24h with PIC with or without
Mcl-1 overexpression (n = 4, *P,0.01 vs. NI, #P,0.01 vs. NI + PIC). Data are mean 6 SEM.
doi:10.1371/journal.ppat.1002267.g002
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Figure 3. Bim contributes for dsRNA-induced apoptosis and its silencing prevents the proapoptotic effects of Mcl-1 knockdown. A.
Time course analysis of Bim protein expression in INS-1E cells treated with internal dsRNA. Cells were harvested at different time points and Bim
expression was evaluated by Western blot (top) and quantified by densitometry (bottom) (n = 10). B to D. INS-1E cells were transfected with siControl
Mechanisms of Viral-Induced Beta Cell Apoptosis
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of apoptosis by dsRNA is secondary to an early and sustained
downregulation of Mcl-1 protein expression (Figure 7), resulting in
the release of the proapoptotic protein Bim. The unbound Bim
then activates BAX translocation to the mitochondria, mitochon-
drial permeabilization, cytochrome c release, caspases 9 and 3
activation and beta cell apoptosis. Key results obtained with
dsRNA, an intermediary product of viral replication, where
partially confirmed in the context of a beta cell infection by the
diabetogenic enterovirus CVB5.
Apoptosis is the main form of cell death in T1D [38]. Several
virus-induced human diseases are associated with increased
apoptosis in the target cells, including HIV1-associated dementia
[39], cytomegalovirus encephalitis [40] and viral myocarditis [41].
Coxsakieviruses can induce beta cell death by different mecha-
nisms, depending on the strain and multiplicity of infection (MOI)
used [19]. At higher MOIs (.100) necrosis is the preferential
mechanism of cell death, but at lower MOIs a shift towards
apoptosis is observed [19]. Viral triggering of apoptosis depends
on both the host and the virus [42]. The host regulates viral-
induced apoptosis trough the local production of pro-inflamma-
tory cytokines and chemokines [42]. Viral factors leading to
apoptosis include dsRNA [43]. This viral nucleic acid is
recognized by receptors such as the toll-like receptor 3 (TLR3),
the kinase PKR, the helicases melanoma differentiation-associated
gene 5 (MDA5), (which is also a candidate gene for T1D [44]) and
retinoic-acid-inducible protein 1 (RIG-I); these receptors activate
genes involved in both antiviral responses and apoptosis [45]. All
these receptors are expressed in pancreatic beta cells [4,18]. The
pathways downstream of viral recognition/signaling leading to
beta cell apoptosis, however, remained to be clarified. The present
observations provide a coherent hypothesis for the mechanisms
triggering beta cell apoptosis following a viral infection (Figure 7).
Mcl-1 is a pro-survival Bcl-2 family member with a short half-
life (30–180 min), which makes it specially susceptible to changes
in protein translation [35]. Mcl-1 is degraded in the proteasome
[26], and use of a proteasome inhibitor prevented, at least in part,
dsRNA-induced decrease in Mcl-1 expression (present findings).
We also observed that intracellular dsRNA induces an early and
sustained phosphorylation of eIF2a which, as previously shown by
our group, leads to a decrease in total protein translation [18].
This eIF2a phosphorylation is mediated by PKR, a protein kinase
mainly activated by dsRNAs produced during viral replication
[37], but not by PERK (present data). Protein translation
inhibition contributes to an early and progressive decrease in
Mcl-1 protein levels, which is reverted by knocking down PKR.
PKR silencing actually increases Mcl-1 protein expression,
probably due to the ‘‘release’’ of protein translation combined
with an increase in Mcl-1 mRNA induced by dsRNA (Figure 2B).
PKR silencing also prevents dsRNA-induced apoptosis, at least
partially due to this increase in Mcl-1 protein. Mcl-1 protein
stability is partly regulated by multiple sites of phosphorylation,
and JNK-mediated phosphorylation of Mcl-1 increases the rate of
protein degradation [35]. We recently described that JNK
activation contributes to Mcl-1 degradation in beta cells exposed
to the cytokines interleukin-1b + interferon-c [20]. Here, we
observed that dsRNA induces JNK phosphorylation in beta cells,
but JNK inhibition does not prevent Mcl-1 degradation. These
findings indicate that dsRNA mainly regulates Mcl-1 protein
expression via inhibition of protein translation.
Mcl-1 functions as a prosurvivor factor by neutralizing specific
propapoptotic BH3-only proteins; Bim has been described as a
preferential target of Mcl-1 in other cell types [32]. Bim is a BH3-
only protein that presents features of both a ‘‘sensitizer’’, i.e. it
binds to antiapoptotic Bcl-2 protein and displaces the effectors
BAX and BAK [32], and also as an ‘‘activator’’; i.e. through
directly binding to BAX and BAK it promotes their activation and
the induction of the mitochondrial apoptosis pathway [46]. An
imbalance between Mcl-1 and Bim has been shown to trigger
apoptosis in other cell types in the context of cytokine deprivation
[47] and granzyme B [48] activation. We presently observed that
Bim is neutralized by Mcl-1 under basal condition. After dsRNA
exposure or the use of specific siRNAs against Mcl-1, however,
there is an increase in ‘‘free’’ Bim that subsequently activates BAX
and triggers apoptosis (Figure 7). This is suggested by the
observation that a double knockdown of Bim plus Mcl-1
(Figure 3) reverts the proapoptotic effects of Mcl-1 silencing.
Bim can also mediate the pro-apoptotic effects of type I interferons
produced during viral infections [49] and it is targeted by viruses
to evade apoptosis in the host cells [50]. Type I interferons were
induced during both dsRNA and CVB5 exposure (Supplemental
Figure S6). Importantly, inhibition of Bim by specific siRNAs
prevented caspases 9/3 activation and apoptosis in beta cells
infected with the diabetogenic virus CVB5, confirming the key
role of Bim during viral infection of beta cells.
Apoptosis is one of the mechanisms by which the host eliminates
virus-infected cells and blocks viral spread [51]. In postmitotic and
poorly proliferating cells such as neurons and beta cells, apoptosis
might also promote functional loss and disease. Indeed, studies in
viral-induced neuronal disease demonstrate that inhibition of
apoptosis may reduce disease severity without changes in virus titers
[52,53]. In line with these findings, apoptosis prevention in beta cells
by knocking down Bim did not modify viral replication in vitro.
In conclusion, we presently show that decreased expression of the
anti-apoptotic protein Mcl-1, coupled to activation of the pro-
apoptotic protein Bim, contributes to beta cell apoptosis during in
vitro exposure to the viral mimetic dsRNA. In case these observations
can be confirmed in future in vivo experiments, novel strategies to
increase Mcl-1 or decrease Bim expression in pancreatic beta cells
[24] may turn to be interesting approaches to protect beta cells
during infection by putative ‘‘diabetogenic’’ viruses.
Methods
Ethics statement
This study was carried out in strict accordance with the
recommendations in the Belgian Regulations for Animal Care
guidelines. The protocol was approved by the Commission
or a specific siRNA against Bim (siBim) for 24 h and then exposed to intracellular dsRNA for 24h. Bim knockdown was confirmed by Western blot (B).
Cell viability (C) was measured using nuclear dyes (n = 3, *P,0.01 vs. siControl, #P,0.05 vs. siControl + PIC). Activation of caspases 9 and 3 (D) was
determined in the presence or not of Bim silencing. E. INS-1E cells were left untreated or transfected with dsRNA for 24h and then subjected to
immunoprecipitation with an antibody against Bim (IP). The presence of Mcl-1 and Bim in the immunoprecipitated material was determined using
specific antibodies, and the ratio Mcl-1/Bim band intensity determined by densitometry. The total lysate (Lysate) was evaluated by Western blotting
with anti-Bim and anti-a-tubulin antibodies. The pictures shown are representative of 3–4 independent experiments. INS-1E cells (F and G) or FACS-
purified primary beta cells (H) were transfected with siControl, siBim, siMcl-1 or a combination of siBim plus siMcl-1. After a 24h recovery period they
were then exposed to internal dsRNA for 24 h. Cell viability (F and H) and cleavage of caspases 9 and 3 (G) were determined after 24h exposure to
dsRNA (n= 3 - 5, *P,0.01 vs. siControl,#P,0.05 vs. siControl + PIC,##P,0.01 vs. siControl + PIC, 1P,0.01 vs. siMcl-1 + PIC). The pictures shown are
representative of 3 independent experiments. Data are mean 6 SEM.
doi:10.1371/journal.ppat.1002267.g003
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Figure 4. CVB5 infection induces apoptosis in beta cells via the BH3-only protein Bim. A to G. INS-1E cells (A to E) or FACS-purified primary
beta cells (F and G) were infected with CVB5 at the indicated MOIs, as described in Methods. Protein expression of the viral capsids was evaluated by
immunocytochemistry at 24h using an enterovirus-specific antibody (A). Cell apoptosis (B) and caspases 9 and 3 cleavage (C) were determined in cells
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d’Ethique du Bien-Eˆtre Animal (CEBEA) on the Ethics of Animal
Experiments of the Universite´ Libre de Bruxelles (Permit Number:
LA 1230351). All procedures was performed under Isoflurane
anesthesia, and all efforts were made to minimize suffering.
Culture of INS-1E cells and primary rat beta cells
The rat pancreatic beta cell line INS-1E (passages 57–75; a kind
gift from Dr. C. Wollheim, Centre Medical Universitaire, Geneva,
Switzerland) was cultured in medium containing RPMI 1640
GlutaMAX-I and 5% heat-inactivated fetal bovine serum (FBS)
[54].
Male Wistar rats (Charles River Laboratories, Brussels,
Belgium) were housed and used according to the Belgian
Regulations for Animal Care guidelines. Rat islets were isolated
by collagenase digestion of the pancreases. In order to obtain
purified beta cells, the islets were dispersed and submitted to
autofluorescence-activated cell sorting (FACS Aria, BD Biosci-
ence, San Jose, USA) as previously described [33,55]. The
preparations used in the present study contained 9362% of beta
cells (n = 10). FACS-purified beta cells were cultured in Ham’s F-
10 medium containing 10 mM glucose, 5% FBS, 0.5% charcoal-
absorbed bovine serum albumin (BSA Fraction V, Boehringer,
Indianapolis, USA) [33]. During dsRNA and siRNAs transfection
cells were cultured in medium without antibiotics and BSA.
RNA interference
The sequences of the siRNAs used are provide in Supplemental
Table S1. As control we used Allstars Negative Control siRNA
(Qiagen, Venlo, Netherlands). We have previously shown that this
negative control siRNA does not affect beta cell gene expression or
insulin release as compared to non-transfected cells [20,56]. The
optimal conditions for siRNAs transfection were determined by
using a FITC-coupled siRNA (Thermo Scientific) and functional/
viability tests [57]. Cells were transfected overnight with 30 nM of
siRNAs using Lipofectamine 2000 or RNAiMAX (Invitrogen, CA,
USA) according to the manufacturer’s instructions [56]. After a
recovery period of 24 to 48 h, cells were treated with a synthetic
dsRNA or infected by an enterovirus.
Double-stranded RNA transfection, JNK and proteasome
inhibition
The synthetic dsRNA polyinosinic-polycytidylic acid (PIC;
Sigma, St. Louis, USA) was used at the concentration of 1 mg/
ml [18]. All experiments were made with intracellular PIC,
achieved via cell transfection under the same conditions as for
siRNAs. Cells exposed to the transfectant alone were used as
Control. Since cytoplasmic helicases can recognize dsRNA
molecules based on their length [58], a PIC formulation with
broad lengths of dsRNAs (10–10,000 bp) was used for the
experiments.
The JNK inhibitor SP600125, the ER stressor thapsigargin
(Sigma) and the proteasome inhibitor MG-132 were used at
concentration of 10 mM, 1 mM and 1 mM respectively [20,34].
SP600125 was added to the cell medium 4h before PIC
transfection and maintained during the whole period of PIC
exposure.
Coxsackievirus infection
The prototype strain of enterovirus (CVB5/Faulkner) was
obtained from American Type Culture Collection (Manassas,
VA). This virus was passaged in Green Monkey Kidney cells. The
identity of the enterovirus preparations used was confirmed using
a plaque neutralization assay with type-specific antisera [12].
Cells were infected with different multiplicity of infection
(MOIs) of the virus preparation diluted in Hanks’ Balanced Salt
Solution (HBSS, Invitrogen). After adsorption for 1h at 37uC, the
inoculum virus was removed, and the cells were washed twice with
HBSS. Culture medium was then added to the plates and the virus
was allowed to replicate for the indicated periods.
Infection with adenoviral vectors
INS-1E cells and primary FACS-purified rat beta cells were
infected for 2 h at different MOIs with an adenovirus encoding
Luciferase (Ad-Luc), or with an adenovirus encoding rat Mcl-1
(Vector Biolabs, Philadelphia, PA, USA) [20]. After 48 h of
recovery cells were exposed to intracellular PIC for 24h.
Assessment of cell viability
Cells were incubated for 15 minutes with the DNA-binding dyes
Propidium Iodide (PI, 5 mg/ml, Sigma) and Hoechst 33342 (HO,
5 mg/ml, Sigma). Subsequently, two independent observers deter-
mined the percentage of viable, apoptotic and necrotic cells. One
of the observers was unaware of sample identity and the
agreement between the results obtained was .90%. At least 500
cells were counted in each experimental condition. Results are
presented as percentage of apoptosis, calculated as number of
apoptotic cells/total number of cells x 100. This method is
quantitative and has been validated for use in primary beta cells
and INS-1E cells by systematic comparison with electron
microscopy, caspase 3 activation and DNA laddering
[33,34,57,59,60]. The apoptotic index was calculated against the
percentage of apoptotic cells in the untreated condition as
previously described [27]. In selected experiments, apoptosis was
confirmed by analysis of activated (cleaved) caspase 3 and 9,
cytoplasmic cytochrome c release and BAX translocation to the
mitochondria (see below).
Assessment of cytochrome c release
Cells were harvested in cold PBS, centrifuged (500 g for 2 min),
resuspended with 50 ml lysis buffer (75 mM NaCl, 1 mM
NaH2PO4, 8 mM Na2PO4, 250 mM sucrose, 21 mg/ml aprotinin,
1 mM PMSF and 0.8 mg/ml digitonin) and vortexed for 30 s.
Following centrifugation at 20,000 g for 1 min the supernatant
was retrieved as the cytoplasmic fraction. The remaining pellet
was resuspended in 50 ml lysis buffer containing a higher digitonin
concentration (8 mg/ml), centrifuged at 20,000 g for 1 min and the
supernatant retrieved as the mitochondrial fraction. Equal
amounts of proteins were then resolved by 14% SDS-PAGE gel
[22]. In addition to anti-cytochrome c (BD Biosciences), the
immunoblots were probed with antibodies against b-actin and
apoptosis-inducing factor (AIF) (Cell Signaling, Danvers, USA)
corresponding to a cytoplasmic and a mitochondrial control,
respectively.
infected or not with CVB5 for 24 h. (n = 3, *P,0.01 vs. uninfected, 1P,0.01 vs. MOI 5). D to G. INS-1E cells (D) or primary beta cells (G) were
transfected with siControl or a specific siRNA against Bim (siBim) for 24 h and then infected with CVB5 at the MOI 5. Cell viability was determined
after 18h (D and G) (n = 3, *P,0.01 vs. siControl, #P,0.05 vs. siControl + PIC). Bim knockdown, caspases 9 and 3 cleavage and the expression of the
viral capsids (VP1 and 2) were evaluated by Western blot (E and F). The pictures shown are representative of 3 independent experiments. Data are
mean 6 SEM.
doi:10.1371/journal.ppat.1002267.g004
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Figure 5. Internal dsRNA induces eIF2a and JNK phosphorylation. Cell lysates of INS-1E cells transfected with dsRNA for different time points
were used for Western blotting with antibodies against p-eIF2a (A) or p-JNK (B). Densitometry was performed and the results were normalized for the
expression of total eIF2a (A) or a-tubulin (B) (n = 5, *P,0.01 vs. untreated, **P,0.05 vs. untreated). The pictures shown are representative of 5
independent experiments. Data are mean 6 SEM.
doi:10.1371/journal.ppat.1002267.g005
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Figure 6. dsRNA-induced decrease in Mcl-1 protein expression depends on eIF2a phosphorylation by PKR. A to E. Cells were
transfected with siControl or a siRNA against PKR (siPKR) and 48h after recovery treated with internal dsRNA for different time points. The expression
of PKR (A), p-eIF2a (B) and Mcl-1 (C) was determined by Western blot (left) and quantified by densitometry (right) in INS-1 E cells (n = 4, *P,0.01 vs.
siControl + PIC at the same time point). Cleavage of caspase 9 and 3 (D) and cell viability (E) were evaluated after 24h of dsRNA exposure with or
without siPKR (n = 5, *P,0.01 vs. siControl, **P,0.05 vs. siControl, #P,0.01 vs. siControl + PIC). The pictures shown are representative of 4-5
independent experiments. Data are mean 6 SEM.
doi:10.1371/journal.ppat.1002267.g006
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mRNA extraction and real time PCR
mRNA was obtained using the Dynabeads mRNA DIRECT kit
(Invitrogen Dynal, Oslo, Norway), and reverse transcribed to
obtain the complementary DNA [33]. This material was analyzed
by real time PCR reaction using SYBR Green fluorescence on a
LightCycler instrument (Roche, Manheim, Germany) and corre-
lated to a standard curve. Expression of the gene of interest was
then corrected for the housekeeping gene glyceraldehyde-3-
phosphate dehydrogenase (GAPDH). The values are normalized
by the highest value of each experiment considered as 1. GAPDH
was chosen as housekeeping gene because its expression is not
modified by PIC treatment in insulin producing cells [33,61].
Primers sequences are described in Supplemental Table S2.
Western blot analysis
Cells were washed with cold PBS and lysed with either Laemmli
buffer or Phospho lysis buffer [4]. Equal amounts of proteins were
then resolved by 10–14% SDS-PAGE gel and transferred to a
Figure 7. Schematic representation of dsRNA- and virus-induced beta cell apoptosis. During viral infection of beta cells the viral by-
product dsRNA is released into the cytoplasm. 1) Cytoplasmic dsRNA activates the kinase PKR that in turn phosphorylates the elongation factor eIF2a;
2) phosphorylation of eIF2a leads to inhibition of protein translation with consequent decrease of Mcl-1 expression; 3) reduction of Mcl-1 protein
increases unbound Bim, which activates BAX; 4) BAX translocates to the mitochondria; 5) BAX oligomerizes and induces permeabilization of the
mitochondrial outer membrane, allowing the release of cytochrome c to the cytoplasm; 6) cytoplasmic cytochrome c forms complexes with Apaf1
and activates the initiator caspase 9; 7) finally, caspase 9 cleaves and activates the executioner caspase 3, 8) triggering the final steps of beta cell
apoptosis; 9) further studies are required to clarify additional pathways implicated in virus-induced beta cell apoptosis.
doi:10.1371/journal.ppat.1002267.g007
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nitrocellulose membrane. Immunoblot analysis was performed
with antibodies targeting Mcl-1 (Biovision, CA, USA), PKR, total
eIF2a (Santa Cruz Biotechnology, CA, USA), phospho-JNK,
cleaved caspases 3 and 9, phospho-eIF2a, phospho-PERK, total
PERK, Bcl-XL, Bcl-2, Bim (Cell Signaling), enterovirus-specific
polyclonal rabbit antiserum (1/600; KTL-510) [12] or a-tubulin
(Sigma), used as housekeeping protein. Horseradish peroxidase-
conjugated donkey anti-rabbit or anti-mouse IgG were used as
secondary antibodies (Lucron Bioproducts, De Pinte; Belgium).
Immunoreactive bands were revealed using a chemiluminescent
substrate (Thermo Scientific) and detected by a LAS-3000 CCD
camera (Fujifilm, Tokyo, Japan). The densitometry of the bands
was evaluated using the Aida Analysis software (Raytest,
Straubenhardt, Germany).
Immunoprecipitation
For the immunoprecipitation, INS-1E cells were lysed on ice
using immunoprecipitation buffer [31]. Total proteins were
quantified and used as the starting material for immunoprecipi-
tations. Equal amounts of proteins were incubated with rabbit
anti-BIM antibody overnight at 4uC with gentle rocking.
Antibody-protein complexes were retrieved with a 50% protein
A-agarose slurry (Santa Cruz Biotechnology), washed with
immunoprecipitation buffer, resuspended in SDS sample buffer
and then boiled to separate antibody-protein complex from the
protein A. Samples were subjected to 14% SDS-PAGE gel and
immunoblotted with anti-a-tubulin (Sigma), anti-Mcl-1 (Biovision)
or anti-BIM antibody (Cell Signaling).
Immunofluorescence
Beta cells were plated on polylysine-coated glass culture slides (BD
Biosciences). Cells were fixed for 15 min in 4% paraformaldehyde,
washed with PBS and permeabilized for 5 min in Triton X-100
0.1%. Slides were then blocked using goat serum 5% and incubated
overnight at 4uC in the presence of rabbit anti-Bax (1/1000; Santa
Cruz Biotechnology) plus mouse anti-ATP Synthase b (mitochon-
drial marker) (1/2000; BD Biosciences) or an enterovirus-specific
rabbit antiserum (1/600; KTL-510). Cells were washed next morning
with PBS and incubated for 1 h with the appropriate Alexa fluor 488
or 555-conjugated antibodies (1/1000; Invitrogen). After, cells were
stained with Hoechst, mounted and photographed using fluorescence
microscopy (Axio Imager, Carl Zeiss, Zaventem, Belgium) [20].
Statistical analysis
Data are presented as mean 6 SEM. Comparisons were
performed by two-tailed paired Student’s t-test or by ANOVA
followed by Student’s t test with Bonferroni correction, as adequate.
A P value , 0.05 was considered as statistically significant.
Gene IDs
Numbers were taken from GenBank at Pubmed: myeloid cell
leukemia sequence 1 (Mcl-1) - 60430; BCL2-like 11 (Bim) - 64547;
B-cell lymphoma 2 (Bcl-2) - 24224; Bcl-2 extra-large (Bcl-XL) -
24888; dsRNA-dependent protein kinase (PKR) - 54287; p53 Up-
regulated Modulator of Apoptosis (PUMA) - 317673; Death
Protein-5 (DP5) - 117271; c-jun NH2-terminal kinase (JNK) -
116554; eukaryotic translation initiation factor 2A (eIF2a) -
502531; PRK-like endoplasmic reticulum kinase (PERK) - 29702.
Supporting Information
Figure S1 Knockdown of Bcl-XL or Bcl-2 increase beta cell
apoptosis. A and B.Western blot (top) and densitometry (bottom) of
INS-1E cells transfected with dsRNA for different time points
(n= 4–7, *P,0.05 vs. untreated). C to H. INS-1E cells were
transfected with siControl or with specific siRNAs against Bcl-XL
(siBcl-XL) or Bcl-2 (siBcl-2) and 48 h later exposed to internal
dsRNA for 24 h. The knockdown of Bcl-XL (C) and Bcl-2 (D) was
assessed by Western blot and quantified by densitometry. Results
are normalized for the expression level of a-tubulin (n= 3, *P,0.01
vs. siControl, #P,0.05 vs. siControl + PIC). E and F. Apoptosis of
INS-1E cells transfected with siControl, siBcl-XL or siBcl-2 and 48
later treated or not with dsRNA for 24 h was evaluated using HO/
PI staining (n= 4, *P,0.01 vs. siControl, #P,0.01 vs. siControl +
PIC). G and H. Cleaved caspases 9 and 3 and a-tubulin protein
expression was evaluated by Western blot in the presence or not of
Bcl-XL (G) or Bcl-2 (H) knockdown. Pictures are representative of 3
independent experiments. Data are mean 6 SEM.
(TIF)
Figure S2 Confirmatory effects on beta cell viability with second
and independent siRNAs against Bcl-XL or Bcl-2. A and B. INS-1E
cells were transfected with siControl, siBcl-XL #2 (A) or siBcl-2 #2
(B) and 48 h after recovery exposed or not to internal dsRNA for
24 h. Cell viability was evaluated using HO/PI (n=4–6, *P,0.01 vs.
siControl, #P,0.01 vs. siControl + PIC). Data are mean 6 SEM.
(TIF)
Figure S3 Mcl-1, but not Bcl-XL or Bcl-2, knockdown sensitizes
INS-1E cells to dsRNA-induced apoptosis. A to C. Cells were
transfected with siControl or with two different siRNAs against
Mcl-1 (siMcl-1 and siMcl-1 #2), Bcl-XL (siBcl-XL and siBcl-XL
#2) or Bcl-2 (siBcl-2 and siBcl-2 #2) as described in Methods.
48 h after recovery, the cells were treated or not with internal
dsRNA for 24 h. Apoptosis was measured using HO/PI staining
and the apoptotic index was calculated as described previously
using siControl, siMcl-1 (siMcl-1 and siMcl-1 #2), siBcl-XL (siBcl-
XL and siBcl-XL #2) or siBcl-2 (siBcl-2 and siBcl-2 #2) without
dsRNA exposure as respective baseline [27] (n = 4–5, *P,0.05 vs.
siControl, **P,0.01 vs. siControl). Data are mean 6 SEM.
(TIF)
Figure S4 A second siRNA against Bim also prevents dsRNA-
induced beta cell apoptosis. A and B. Bim was silenced by using a
second independent siRNA (siBim #2) for 24 h. The knockdown
of Bim was assessed by Western blot (A), and the cell viability (B)
by the use of nuclear dies 24 h after PIC exposure (n = 3–6,
*P,0.01 vs. siControl, #P,0.01 vs. siControl + PIC). The
pictures shown are representative of 3 independent experiments.
Data are mean 6 SEM.
(TIF)
Figure S5 DP5 and PUMA are not mediators of beta cell
apoptosis triggered by internal dsRNA. A to D. DP5 and PUMA
were silenced by using specific siRNAs for 48 h. The knockdown was
assessed by real time RT-PCR (A and C), and the cell viability (B and
D) by using nuclear dies 24 h after PIC exposure (n=3–4, *P,0.01
vs. siControl,#P,0.01 vs. siControl + PIC). Data are mean6 SEM.
(TIF)
Figure S6 Intracellular dsRNA and CVB5 induce interferon b
expression. A and B. INS-1E cells were exposed to dsRNA (A) or
CVB5 (B) for different time points and interferon b mRNA
expression was analyzed by RT-PCR (n= 3, *P,0.01 vs.
untreated). C. Interferon b mRNA expression after 24 h of PIC
exposure in primary beta cells and INS-1E cells (n = 3–4).
(TIF)
Figure S7 The Mcl-1 degradation induced by dsRNA is not
dependent of JNK activation. Analysis of JNK phosphorylation
and Mcl-1 protein expression in INS-1E cells treated with dsRNA
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for different time points in the presence or absence of a JNK
chemical inhibitor (SP600125) was done by Western blot (left) and
quantified by densitometry (right). Mcl-1 expression was normal-
ized to a-tubulin (n = 4, *P,0.01 vs. untreated). The pictures
shown are representative of 4 independent experiments. Data are
mean 6 SEM.
(TIF)
Figure S8 Internal dsRNA does not induce PERK phosphor-
ylation. A and B. Cells were transfected with dsRNA, as described
in Methods, and harvested at different time points. The ER
stressor thapsigargin 1 mM was used as a positive control.
Phosphorylation of PERK and eIF2a was determined by Western
blot (A) and quantified by densitometry (B) relatively to total
PERK and total eIF2a respectively (n = 5, *P,0.01 vs. untreated).
The pictures shown are representative of 5 independent
experiments. Data are mean 6 SEM.
(TIF)
Table S1 siRNAs used for silencing of selected genes.
(DOC)
Table S2 Primer sequences and their respective PCR fragment
lengths.
(DOC)
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